| Firm Name | Analyst Name | | Barclays Capital | Josh Raskin | | BMO Capital Markets | Dave Shove | | Citigroup Smith Barney | Charles Boorady | | Collins Stewart | Brian Wright | | Cowen and Company | Christine Arnold | | Credit Suisse First Boston | Greg Nersessian | | Deutsche Bank | Scott Fidel | | Dowling & Partners | Samuel W. Levitt, ScD | | Goldman Sachs | Matthew Borsch | | JPMorgan | John Rex | | Leerink Swann | Jason Gurda | | Morgan Stanley | Doug Simpson | | Oppenheimer & Company | Carl McDonald | | Raymond James and Associates | Michael Baker | | Sanford Bernstein | Ana Gupte | | Stifel Nicolaus | Thomas Carroll | | UBS Securities | Justin Lake | | Wachovia Securities | Matt Perry | | Williams Capital | Beth Senko |
|
 |
| Coventry Health Care, Inc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Coventry Health Care, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Coventry Health Care, Inc or its management. Coventry Health Care, Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
| | Investor Tool Kit |
